Jazz Pharmaceuticals
JAZZ
#2203
Rank
NZ$11.28 B
Marketcap
$185.80
Share price
1.67%
Change (1 day)
3.05%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.36. In 2022 the company made an earnings per share (EPS) of -$5.94 an increase over its 2021 EPS that were of -$9.02.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-64.1%
2022-$5.94-34.2%
2021-$9.02-224.83%
2020$7.23-53.25%
2019$15.4623.59%
2018$12.51-8.24%
2017$13.6323.74%
2016$11.0222.12%
2015$9.02478.49%
2014$1.56-74.93%
2013$6.22-27.11%
2012$8.5469.1%
2011$5.05245.98%
2010$1.46-462.5%
2009-$0.40-96.7%
2008-$12.21-27.04%
2007-$16.7365.47%
2006-$10.11-4.59%
2005-$10.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.74 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$13.90-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.27-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.35 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel